Michael W. Schwartz - Publications

Affiliations: 
University of Washington School of Medicine, Seattle, WA, United States 

274 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bentsen MA, Rausch DM, Mirzadeh Z, Muta K, Scarlett JM, Brown JM, Herranz-Pérez V, Baquero AF, Thompson J, Alonge KM, Faber CL, Kaiyala KJ, Bennett C, Pyke C, Ratner C, ... ... Schwartz MW, et al. Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission. Nature Communications. 11: 4458. PMID 32895383 DOI: 10.1038/S41467-020-17720-5  0.329
2020 BROWN JM, PHAN BAN, WASANWALA H, MATSEN ME, SECHER A, MORTON GJ, SCHWARTZ MW, SCARLETT J. 214-OR: Role of Hypothalamic MAPK/ERK Signaling in Diabetes Remission Induced by the Central Action of Fibroblast Growth Factor 1 (FGF1) Diabetes. 69: 214-OR. DOI: 10.2337/Db20-214-Or  0.323
2020 DEEM JD, FABER CL, PEDERSEN C, PHAN BAN, OGIMOTO K, LARSEN SA, TRAN MA, DAMIAN V, KAIYALA K, SCARLETT J, BRUCHAS MR, SCHWARTZ MW, MORTON GJ. 209-OR: Evidence that Agrp Neuron Activation Drives Cold-Induced Hyperphagia Diabetes. 69: 209-OR. DOI: 10.2337/Db20-209-Or  0.34
2020 ALONGE KM, MIRZADEH Z, SCARLETT J, LOGSDON A, BROWN JM, CABRALES E, CHAN CK, KAIYALA K, BENTSEN MA, BANKS WA, GUTTMAN M, WIGHT TN, MORTON GJ, SCHWARTZ MW. 1771-P: Hypothalamic Perineuronal Net Assembly Is Required for Sustained Diabetes Remission Induced by FGF1 Diabetes. 69: 1771-P. DOI: 10.2337/Db20-1771-P  0.32
2020 Alonge KM, Mirzadeh Z, Scarlett JM, Brown JM, Bentsen MA, Logsdon AF, Banks WA, Guttman M, Wight TN, Morton GJ, Schwartz MW. Assembly of Hypothalamic Perineuronal Nets Contributes to Sustained Blood Glucose Lowering by FGF1 Action in the Brain The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05961  0.309
2019 Brown JM, Scarlett JM, Schwartz MW. Rethinking the role of the brain in glucose homeostasis and diabetes pathogenesis. The Journal of Clinical Investigation. 130. PMID 31329157 DOI: 10.1172/Jci130904  0.301
2019 Tateya S, Rizzo-De Leon N, Cheng AM, Dick BP, Lee WJ, Kim ML, O'Brien K, Morton GJ, Schwartz MW, Kim F. The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression. Plos One. 14: e0215601. PMID 31017943 DOI: 10.1371/Journal.Pone.0215601  0.319
2019 Hultman K, Scarlett JM, Baquero AF, Cornea A, Zhang Y, Salinas CBG, Brown J, Morton GJ, Whalen EJ, Grove KL, Koegler FH, Schwartz MW, Mercer AJ. The central fibroblast growth factor receptor/beta klotho system: comprehensive mapping in mus musculus and comparisons to non-human primate and human samples using an automated in situ hybridization platform. The Journal of Comparative Neurology. PMID 30809795 DOI: 10.1002/Cne.24668  0.363
2019 Brown JM, Scarlett JM, Matsen ME, Nguyen HT, Secher A, Jorgensen R, Morton GJ, Schwartz MW. The Hypothalamic Arcuate Nucleus-Median Eminence is a Target for Sustained Diabetes Remission Induced by Fibroblast Growth Factor 1. Diabetes. PMID 30796029 DOI: 10.2337/Db19-0025  0.375
2019 Muta K, Matsen ME, Acharya NK, Stefanovski D, Bergman RN, Schwartz MW, Morton GJ. Glucoregulatory responses to hypothalamic preoptic area cooling. Brain Research. PMID 30610874 DOI: 10.1016/J.Brainres.2019.01.002  0.403
2019 DEEM JD, OGIMOTO K, NELSON J, PHAN BAN, VELASCO KR, DAMIAN V, SCHWARTZ MW, MORTON GJ. 98-OR: Cold-Induced Hyperphagia Requires AgRP Neuron Activation Diabetes. 68: 98-OR. DOI: 10.2337/Db19-98-Or  0.375
2019 FABER CL, HARVEY TJ, VELASCO KR, DAMIAN V, SCHWARTZ MW, MORTON GJ. 1824-P: Leptin Receptor Neurons in the Hypothalamic Ventromedial Nucleus Play a Physiological Role in Regulating Glucose Tolerance Diabetes. 68: 1824-P. DOI: 10.2337/Db19-1824-P  0.391
2019 MIRZADEH Z, CABRALES E, SCHWARTZ MW. 1823-P: Evidence that Arcuate Nucleus Neurocircuit Remodeling Ameliorates Hyperglycemia in Type 2 Diabetes Diabetes. 68: 1823-P. DOI: 10.2337/Db19-1823-P  0.386
2019 BENTSEN MA, RAUSCH D, MIRZADEH Z, SCARLETT J, BROWN JM, ALONGE KM, MEEK TH, SECHER A, JORGENSEN R, PERS T, SCHWARTZ MW. 1800-P: Transcriptomic Evidence of a Role for Neuron-Glia Interactions in Diabetes Remission Induced by the Central Action of Fibroblast Growth Factor 1 (FGF-1) Diabetes. 68: 1800-P. DOI: 10.2337/Db19-1800-P  0.342
2018 Bentsen MA, Mirzadeh Z, Schwartz MW. Revisiting How the Brain Senses Glucose-And Why. Cell Metabolism. PMID 30527741 DOI: 10.1016/J.Cmet.2018.11.001  0.339
2018 Scarlett JM, Muta K, Brown JM, Rojas JM, Matsen ME, Acharya NK, Secher A, Ingvorsen C, Jorgensen R, Høeg-Jensen T, Stefanovski D, Bergman RN, Piccinini F, Kaiyala KJ, Shiota M, ... ... Schwartz MW, et al. Peripheral Mechanisms Mediating the Sustained Anti-Diabetic Action of FGF1 in the Brain. Diabetes. PMID 30523024 DOI: 10.2337/Db18-0498  0.388
2018 Faber CL, Matsen ME, Velasco KR, Damian V, Phan BA, Adam D, Therattil A, Schwartz MW, Morton GJ. Distinct Neuronal Projections from the Hypothalamic Ventromedial Nucleus Mediate Glycemic and Behavioral Effects. Diabetes. PMID 30257978 DOI: 10.2337/Db18-0380  0.363
2018 BENTSEN MA, RAUSCH D, SCARLETT J, ALONGE KM, TIMSHEL PN, MIRZADEH Z, SECHER A, JORGENSEN R, PERS T, SCHWARTZ MW. A Single-Cell Transcriptomics Roadmap to Investigate Diabetes Remission Induced by the Central Action of Fibroblast Growth Factor-1 (FGF-1) Diabetes. 67: 375-OR. DOI: 10.2337/Db18-375-Or  0.308
2018 SCARLETT J, BROWN JM, PHAN BAN, KHAV EL, MATSEN ME, ACHARYA NK, NGUYEN HT, SECHER A, JORGENSEN R, MORTON GJ, SCHWARTZ MW. Sustained Diabetes Remission Induced by the Central Action of Fibroblast Growth Factor-1 (FGF-1) Requires Activation of Integrin Receptor aνß3 Diabetes. 67: 373-OR. DOI: 10.2337/Db18-373-Or  0.348
2018 BROWN JM, SCARLETT J, MATSEN ME, SECHER A, JORGENSEN R, MORTON GJ, SCHWARTZ MW. An Action in the Hypothalamic Arcuate Nucleus Is Sufficient to Explain the Sustained Remission of Diabetes Induced by Central Administration of Fibroblast Growth Factor-1 (FGF-1) Diabetes. 67: 372-OR. DOI: 10.2337/Db18-372-Or  0.34
2018 DEEM JD, OGIMOTO K, VELASCO KR, DAMIAN V, KNIGHT Z, SCHWARTZ MW, MORTON GJ. Identification of Warm-Sensitive Neurons in the Hypothalamic Preoptic Area as Powerful Regulators of Glucose Homeostasis Diabetes. 67: 246-LB. DOI: 10.2337/Db18-246-Lb  0.362
2017 Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL. Obesity Pathogenesis: An Endocrine Society Scientific Statement. Endocrine Reviews. 38: 267-296. PMID 28898979 DOI: 10.1210/Er.2017-00111  0.37
2017 Roberts ZS, Wolden-Hanson TH, Matsen ME, Ryu V, Vaughan CH, Graham JL, Havel PJ, Chukri DW, Schwartz MW, Morton GJ, Blevins JE. Chronic Hindbrain Administration of Oxytocin is Sufficient to Elicit Weight Loss in Diet-Induced Obese Rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00169.2017. PMID 28747407 DOI: 10.1152/Ajpregu.00169.2017  0.449
2017 Deem JD, Muta K, Scarlett JM, Morton GJ, Schwartz MW. How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes? Diabetes. PMID 28603139 DOI: 10.2337/Dbi16-0067  0.378
2017 Campos CA, Bowen AJ, Han S, Wisse BE, Palmiter RD, Schwartz MW. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus. Nature Neuroscience. PMID 28581479 DOI: 10.1038/Nn.4574  0.344
2017 Morton GJ, Muta K, Kaiyala KJ, Rojas JM, Scarlett JM, Matsen ME, Nelson JT, Acharya NK, Piccinini F, Stefanovski D, Bergman RN, Taborsky GJ, Kahn SE, Schwartz MW. Evidence that the Sympathetic Nervous System Elicits Rapid, Coordinated and Reciprocal Adjustments of Insulin Secretion and Insulin Sensitivity During Cold Exposure. Diabetes. PMID 28115396 DOI: 10.2337/Db16-1351  0.394
2017 Dorfman MD, Krull JE, Scarlett JM, Guyenet SJ, Sajan MP, Damian V, Nguyen HT, Leitges M, Morton GJ, Farese RV, Schwartz MW, Thaler JP. Deletion of Protein Kinase C Lambda in POMC Neurons Predisposes to Diet-Induced Obesity. Diabetes. PMID 28073831 DOI: 10.2337/Db16-0482  0.497
2016 Scarlett JM, Rojas JM, Matsen ME, Kaiyala KJ, Stefanovski D, Bergman RN, Nguyen HT, Dorfman MD, Lantier L, Wasserman DH, Mirzadeh Z, Unterman TG, Morton GJ, Schwartz MW. Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents. Nature Medicine. PMID 27213816 DOI: 10.1038/Nm.4101  0.349
2016 Campos CA, Bowen AJ, Schwartz MW, Palmiter RD. Parabrachial CGRP Neurons Control Meal Termination. Cell Metabolism. 23: 811-20. PMID 27166945 DOI: 10.1016/J.Cmet.2016.04.006  0.369
2016 Meek TH, Nelson JT, Matsen ME, Dorfman MD, Guyenet SJ, Damian V, Allison MB, Scarlett JM, Nguyen HT, Thaler JP, Olson DP, Myers MG, Schwartz MW, Morton GJ. Functional identification of a neurocircuit regulating blood glucose. Proceedings of the National Academy of Sciences of the United States of America. PMID 27001850 DOI: 10.1073/Pnas.1521160113  0.377
2016 Blevins JE, Thompson BW, Anekonda VT, Ho JM, Graham JL, Roberts ZS, Hwang BH, Ogimoto K, Wolden-Hanson TH, Nelson J, Kaiyala KJ, Havel PJ, Bales KL, Morton GJ, Schwartz MW, et al. Chronic CNS Oxytocin Signaling Preferentially Induces Fat Loss in High Fat Diet-Fed Rats by Enhancing Satiety Responses and Increasing Lipid Utilization. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00220.2015. PMID 26791828 DOI: 10.1152/Ajpregu.00220.2015  0.629
2015 Schur EA, Melhorn SJ, Oh SK, Lacy JM, Berkseth KE, Guyenet SJ, Sonnen JA, Tyagi V, Rosalynn M, De Leon B, Webb MF, Gonsalves ZT, Fligner CL, Schwartz MW, Maravilla KR. Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans. Obesity (Silver Spring, Md.). 23: 2142-8. PMID 26530930 DOI: 10.1002/Oby.21248  0.356
2015 Morton GJ, Meek TH, Matsen ME, Schwartz MW. Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin. The Journal of Clinical Investigation. 2015. PMID 26529250 DOI: 10.1172/Jci82723  0.407
2015 Rojas JM, Matsen ME, Mundinger TO, Morton GJ, Stefanovski D, Bergman RN, Kaiyala KJ, Taborsky GJ, Schwartz MW. Glucose intolerance induced by blockade of central FGF receptors is linked to an acute stress response. Molecular Metabolism. 4: 561-8. PMID 26266088 DOI: 10.1016/J.Molmet.2015.05.005  0.394
2015 O-Sullivan I, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, DePinho RA, Stolz DB, Kahn CR, Schwartz MW, Unterman TG. Erratum: FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nature Communications. 6: 7861. PMID 26206703 DOI: 10.1038/Ncomms8861  0.315
2015 O-Sullivan I, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, DePinho RA, Stolz DB, Kahn CR, Schwartz MW, Unterman TG. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nature Communications. 6: 7079. PMID 25963540 DOI: 10.1038/Ncomms8079  0.371
2015 Chen J, Kaiyala KJ, Lam J, Agrawal N, Nguyen L, Ogimoto K, Spencer D, Morton GJ, Schwartz MW, Dichek HL. In vivo structure-function studies of human hepatic lipase: the catalytic function rescues the lean phenotype of HL-deficient (hl-/-) mice. Physiological Reports. 3. PMID 25862097 DOI: 10.14814/Phy2.12365  0.357
2015 Lee WJ, Tateya S, Cheng AM, Rizzo-DeLeon N, Wang NF, Handa P, Wilson CL, Clowes AW, Sweet IR, Bomsztyk K, Schwartz MW, Kim F. M2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling. Diabetes. PMID 25845662 DOI: 10.2337/Db14-1668  0.329
2015 Kaiyala KJ, Ogimoto K, Nelson JT, Schwartz MW, Morton GJ. Leptin signaling is required for adaptive changes in food intake, but not energy expenditure, in response to different thermal conditions. Plos One. 10: e0119391. PMID 25756181 DOI: 10.1371/Journal.Pone.0119391  0.366
2015 Scarlett JM, Schwartz MW. Gut-brain mechanisms controlling glucose homeostasis. F1000prime Reports. 7: 12. PMID 25705395 DOI: 10.12703/P7-12  0.379
2015 Schwartz MW. Can the history of modern endocrinology shape the future of obesity? Molecular Endocrinology (Baltimore, Md.). 29: 155-7. PMID 25629595 DOI: 10.1210/Me.2014-1399  0.341
2015 Blevins JE, Graham JL, Morton GJ, Bales KL, Schwartz MW, Baskin DG, Havel PJ. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 308: R431-8. PMID 25540103 DOI: 10.1152/Ajpregu.00441.2014  0.625
2014 van Praag H, Fleshner M, Schwartz MW, Mattson MP. Exercise, energy intake, glucose homeostasis, and the brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 15139-49. PMID 25392482 DOI: 10.1523/Jneurosci.2814-14.2014  0.32
2014 Rojas JM, Schwartz MW. Control of hepatic glucose metabolism by islet and brain. Diabetes, Obesity & Metabolism. 16: 33-40. PMID 25200294 DOI: 10.1111/Dom.12332  0.4
2014 Laeger T, Henagan TM, Albarado DC, Redman LM, Bray GA, Noland RC, Münzberg H, Hutson SM, Gettys TW, Schwartz MW, Morrison CD. FGF21 is an endocrine signal of protein restriction. The Journal of Clinical Investigation. 124: 3913-22. PMID 25133427 DOI: 10.1172/Jci74915  0.355
2014 Cheng AM, Rizzo-DeLeon N, Wilson CL, Lee WJ, Tateya S, Clowes AW, Schwartz MW, Kim F. Vasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance. American Journal of Physiology. Endocrinology and Metabolism. 307: E571-9. PMID 25117404 DOI: 10.1152/Ajpendo.00303.2014  0.394
2014 Spiezio SH, Amon LM, McMillen TS, Vick CM, Houston BA, Caldwell M, Ogimoto K, Morton GJ, Kirk EA, Schwartz MW, Nadeau JH, LeBoeuf RC. Genetic determinants of atherosclerosis, obesity, and energy balance in consomic mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 25: 549-63. PMID 25001233 DOI: 10.1007/S00335-014-9530-2  0.347
2014 Berkseth KE, Guyenet SJ, Melhorn SJ, Lee D, Thaler JP, Schur EA, Schwartz MW. Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study. Endocrinology. 155: 2858-67. PMID 24914942 DOI: 10.1210/En.2014-1121  0.403
2014 Ho JM, Anekonda VT, Thompson BW, Zhu M, Curry RW, Hwang BH, Morton GJ, Schwartz MW, Baskin DG, Appleyard SM, Blevins JE. Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats. Endocrinology. 155: 2845-57. PMID 24877632 DOI: 10.1210/En.2014-1148  0.657
2014 Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nature Reviews. Neuroscience. 15: 367-78. PMID 24840801 DOI: 10.1038/Nrn3745  0.39
2014 Gao Y, Ottaway N, Schriever SC, Legutko B, García-Cáceres C, de la Fuente E, Mergen C, Bour S, Thaler JP, Seeley RJ, Filosa J, Stern JE, Perez-Tilve D, Schwartz MW, Tschöp MH, et al. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia. 62: 17-25. PMID 24166765 DOI: 10.1002/Glia.22580  0.384
2013 Schwartz MW, Seeley RJ, Tschöp MH, Woods SC, Morton GJ, Myers MG, D'Alessio D. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature. 503: 59-66. PMID 24201279 DOI: 10.1038/Nature12709  0.358
2013 Guyenet SJ, Matsen ME, Morton GJ, Kaiyala KJ, Schwartz MW. Rapid glutamate release in the mediobasal hypothalamus accompanies feeding and is exaggerated by an obesogenic food. Molecular Metabolism. 2: 116-22. PMID 24199157 DOI: 10.1016/J.Molmet.2013.02.001  0.344
2013 Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, Stefanovski D, Bergman RN, Wasserman DH, Schwartz MW. FGF19 action in the brain induces insulin-independent glucose lowering. The Journal of Clinical Investigation. 123: 4799-808. PMID 24084738 DOI: 10.1172/Jci70710  0.379
2013 Thaler JP, Guyenet SJ, Dorfman MD, Wisse BE, Schwartz MW. Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes. 62: 2629-34. PMID 23881189 DOI: 10.2337/Db12-1605  0.403
2013 Schwartz MW, Baskin DG. Leptin and the brain: then and now. The Journal of Clinical Investigation. 123: 2344-5. PMID 23722910 DOI: 10.1172/Jci69346  0.628
2013 Berkseth KE, Schur E, Schwartz MW. A role for natriuretic peptides in the central control of energy balance? Diabetes. 62: 1379-81. PMID 23613557 DOI: 10.2337/Db12-1841  0.449
2013 Lee D, Thaler JP, Berkseth KE, Melhorn SJ, Schwartz MW, Schur EA. Longer T(2) relaxation time is a marker of hypothalamic gliosis in mice with diet-induced obesity. American Journal of Physiology. Endocrinology and Metabolism. 304: E1245-50. PMID 23548614 DOI: 10.1152/Ajpendo.00020.2013  0.338
2013 Guyenet SJ, Nguyen HT, Hwang BH, Schwartz MW, Baskin DG, Thaler JP. High-fat diet feeding causes rapid, non-apoptotic cleavage of caspase-3 in astrocytes. Brain Research. 1512: 97-105. PMID 23548599 DOI: 10.1016/J.Brainres.2013.03.033  0.607
2013 Lu M, Sarruf DA, Li P, Osborn O, Sanchez-Alavez M, Talukdar S, Chen A, Bandyopadhyay G, Xu J, Morinaga H, Dines K, Watkins S, Kaiyala K, Schwartz MW, Olefsky JM. Neuronal Sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues. The Journal of Biological Chemistry. 288: 10722-35. PMID 23457303 DOI: 10.1074/Jbc.M112.443606  0.437
2013 Matsen ME, Thaler JP, Wisse BE, Guyenet SJ, Meek TH, Ogimoto K, Cubelo A, Fischer JD, Kaiyala KJ, Schwartz MW, Morton GJ. In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue. American Journal of Physiology. Endocrinology and Metabolism. 304: E734-46. PMID 23384771 DOI: 10.1152/Ajpendo.00488.2012  0.364
2013 Meek TH, Wisse BE, Thaler JP, Guyenet SJ, Matsen ME, Fischer JD, Taborsky GJ, Schwartz MW, Morton GJ. BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production. Diabetes. 62: 1512-8. PMID 23274899 DOI: 10.2337/Db12-0837  0.405
2012 Mehta S, Melhorn SJ, Smeraglio A, Tyagi V, Grabowski T, Schwartz MW, Schur EA. Regional brain response to visual food cues is a marker of satiety that predicts food choice. The American Journal of Clinical Nutrition. 96: 989-99. PMID 22990034 DOI: 10.3945/Ajcn.112.042341  0.355
2012 Benzler J, Ganjam GK, Krüger M, Pinkenburg O, Kutschke M, Stöhr S, Steger J, Koch CE, Ölkrug R, Schwartz MW, Shepherd PR, Grattan DR, Tups A. Hypothalamic glycogen synthase kinase 3β has a central role in the regulation of food intake and glucose metabolism. The Biochemical Journal. 447: 175-84. PMID 22849606 DOI: 10.1042/Bj20120834  0.455
2012 Buchner DA, Geisinger JM, Glazebrook PA, Morgan MG, Spiezio SH, Kaiyala KJ, Schwartz MW, Sakurai T, Furley AJ, Kunze DL, Croniger CM, Nadeau JH. The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 23: 431-42. PMID 22752552 DOI: 10.1007/S00335-012-9400-8  0.376
2012 Sarruf DA, Bonner-Weir S, Schwartz MW. New clues to bariatric surgery's benefits. Nature Medicine. 18: 860-1. PMID 22673995 DOI: 10.1038/Nm.2801  0.308
2012 Guyenet SJ, Schwartz MW. Clinical review: Regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. The Journal of Clinical Endocrinology and Metabolism. 97: 745-55. PMID 22238401 DOI: 10.1210/Jc.2011-2525  0.426
2012 Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, Nguyen HT, Fischer JD, Matsen ME, Wisse BE, Morton GJ, ... ... Schwartz MW, et al. Obesity is associated with hypothalamic injury in rodents and humans. The Journal of Clinical Investigation. 122: 153-62. PMID 22201683 DOI: 10.1172/Jci59660  0.634
2012 Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Schwartz MW, Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. American Journal of Physiology. Endocrinology and Metabolism. 302: E134-44. PMID 22008455 DOI: 10.1152/Ajpendo.00296.2011  0.672
2012 Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, Nguyen HT, Fischer JD, Matsen ME, Wisse BE, Morton GJ, ... ... Schwartz MW, et al. Obesity is associated with hypothalamic injury in rodents and humans (The Journal of Clinical Investigation (2012) 122, 1, (153-162) DOI: 10.1172/JCI59660) Journal of Clinical Investigation. 122: 778. DOI: 10.1172/Jci62813  0.54
2011 Tateya S, Rizzo NO, Handa P, Cheng AM, Morgan-Stevenson V, Daum G, Clowes AW, Morton GJ, Schwartz MW, Kim F. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes. 60: 2792-801. PMID 21911751 DOI: 10.2337/Db11-0255  0.393
2011 Handa P, Tateya S, Rizzo NO, Cheng AM, Morgan-Stevenson V, Han CY, Clowes AW, Daum G, O'Brien KD, Schwartz MW, Chait A, Kim F. Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2827-35. PMID 21903940 DOI: 10.1161/Atvbaha.111.236554  0.365
2011 Diano S, Liu ZW, Jeong JK, Dietrich MO, Ruan HB, Kim E, Suyama S, Kelly K, Gyengesi E, Arbiser JL, Belsham DD, Sarruf DA, Schwartz MW, Bennett AM, Shanabrough M, et al. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nature Medicine. 17: 1121-7. PMID 21873987 DOI: 10.1038/Nm.2421  0.442
2011 Williams DL, Schwartz MW. Neuroanatomy of body weight control: lessons learned from leptin. The Journal of Clinical Investigation. 121: 2152-5. PMID 21606602 DOI: 10.1172/Jci58027  0.624
2011 Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? The Journal of Clinical Endocrinology and Metabolism. 96: 1654-63. PMID 21602457 DOI: 10.1210/Jc.2011-0585  0.311
2011 Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, Smith RJ, Smith SR. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care. 34: 1424-30. PMID 21602431 DOI: 10.2337/Dc11-0447  0.311
2011 Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G, Nalbandian S, Fan W, Gayen JR, Mahata SK, Webster NJ, Schwartz MW, Olefsky JM. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nature Medicine. 17: 618-22. PMID 21532596 DOI: 10.1038/Nm.2332  0.469
2011 Morton GJ, Schwartz MW. Leptin and the central nervous system control of glucose metabolism. Physiological Reviews. 91: 389-411. PMID 21527729 DOI: 10.1152/Physrev.00007.2010  0.367
2011 Choi SJ, Yablonka-Reuveni Z, Kaiyala KJ, Ogimoto K, Schwartz MW, Wisse BE. Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice. American Journal of Physiology. Endocrinology and Metabolism. 300: E1031-7. PMID 21427410 DOI: 10.1152/Ajpendo.00656.2010  0.37
2011 Velloso LA, Schwartz MW. Altered hypothalamic function in diet-induced obesity. International Journal of Obesity (2005). 35: 1455-65. PMID 21386802 DOI: 10.1038/Ijo.2011.56  0.472
2011 Kaiyala KJ, Schwartz MW. Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes. 60: 17-23. PMID 21193735 DOI: 10.2337/Db10-0909  0.369
2011 German JP, Thaler JP, Wisse BE, Oh-I S, Sarruf DA, Matsen ME, Fischer JD, Taborsky GJ, Schwartz MW, Morton GJ. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology. 152: 394-404. PMID 21159853 DOI: 10.1210/En.2010-0890  0.446
2011 Morton GJ, Kaiyala KJ, Fisher JD, Ogimoto K, Schwartz MW, Wisse BE. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. American Journal of Physiology. Endocrinology and Metabolism. 300: E392-401. PMID 21062956 DOI: 10.1152/Ajpendo.00546.2010  0.334
2010 Koch C, Augustine RA, Steger J, Ganjam GK, Benzler J, Pracht C, Lowe C, Schwartz MW, Shepherd PR, Anderson GM, Grattan DR, Tups A. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 16180-7. PMID 21123564 DOI: 10.1523/Jneurosci.3202-10.2010  0.445
2010 Schwartz MW, Guyenet SJ, Cirulli V. The hypothalamus and ß-cell connection in the gene-targeting era. Diabetes. 59: 2991-3. PMID 21115781 DOI: 10.2337/Db10-1149  0.369
2010 Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends in Endocrinology and Metabolism: Tem. 21: 643-51. PMID 20846876 DOI: 10.1016/J.Tem.2010.08.002  0.402
2010 Ellacott KL, Morton GJ, Woods SC, Tso P, Schwartz MW. Assessment of feeding behavior in laboratory mice. Cell Metabolism. 12: 10-7. PMID 20620991 DOI: 10.1016/J.Cmet.2010.06.001  0.313
2010 Baskin DG, Kim F, Gelling RW, Russell BJ, Schwartz MW, Morton GJ, Simhan HN, Moralejo DH, Blevins JE. A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain. Endocrinology. 151: 4207-13. PMID 20610562 DOI: 10.1210/En.2010-0295  0.64
2010 Thaler JP, Schwartz MW. Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology. 151: 4109-15. PMID 20573720 DOI: 10.1210/En.2010-0336  0.419
2010 German JP, Wisse BE, Thaler JP, Oh-I S, Sarruf DA, Ogimoto K, Kaiyala KJ, Fischer JD, Matsen ME, Taborsky GJ, Schwartz MW, Morton GJ. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes. 59: 1626-34. PMID 20424233 DOI: 10.2337/Db09-1918  0.489
2010 Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes. 59: 1657-66. PMID 20413511 DOI: 10.2337/Db09-1582  0.35
2010 Oh-I S, Thaler JP, Ogimoto K, Wisse BE, Morton GJ, Schwartz MW. Central administration of interleukin-4 exacerbates hypothalamic inflammation and weight gain during high-fat feeding. American Journal of Physiology. Endocrinology and Metabolism. 299: E47-53. PMID 20371733 DOI: 10.1152/Ajpendo.00026.2010  0.398
2010 Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K, Schwartz MW. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes. 59: 1817-24. PMID 20357365 DOI: 10.2337/Db09-1878  0.495
2010 Choi SJ, Kim F, Schwartz MW, Wisse BE. Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids. American Journal of Physiology. Endocrinology and Metabolism. 298: E1122-30. PMID 20354158 DOI: 10.1152/Ajpendo.00006.2010  0.392
2010 Rizzo NO, Maloney E, Pham M, Luttrell I, Wessells H, Tateya S, Daum G, Handa P, Schwartz MW, Kim F. Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 758-65. PMID 20093624 DOI: 10.1161/Atvbaha.109.199893  0.397
2010 Chiu HK, Qian K, Ogimoto K, Morton GJ, Wisse BE, Agrawal N, McDonald TO, Schwartz MW, Dichek HL. Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis. Endocrinology. 151: 993-1001. PMID 20056822 DOI: 10.1210/En.2009-1100  0.41
2010 Thaler JP, Choi SJ, Schwartz MW, Wisse BE. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Frontiers in Neuroendocrinology. 31: 79-84. PMID 19822168 DOI: 10.1016/J.Yfrne.2009.10.002  0.371
2010 Thaler JP, Schwartz MW. Inflammation and Obesity Pathogenesis: The Hypothalamus Heats Up Endocrine Reviews. 31: 600-600. DOI: 10.1210/Edrv.31.4.9998  0.438
2009 Thaler JP, Choi SJ, Sajan MP, Ogimoto K, Nguyen HT, Matsen M, Benoit SC, Wisse BE, Farese RV, Schwartz MW. Atypical protein kinase C activity in the hypothalamus is required for lipopolysaccharide-mediated sickness responses. Endocrinology. 150: 5362-72. PMID 19819945 DOI: 10.1210/En.2009-0509  0.437
2009 Wisse BE, Schwartz MW. Does hypothalamic inflammation cause obesity? Cell Metabolism. 10: 241-2. PMID 19808014 DOI: 10.1016/J.Cmet.2009.09.003  0.413
2009 Williams DL, Baskin DG, Schwartz MW. Hindbrain leptin receptor stimulation enhances the anorexic response to cholecystokinin. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 297: R1238-46. PMID 19726710 DOI: 10.1152/Ajpregu.00182.2009  0.733
2009 German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, Morton GJ. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology. 150: 4502-11. PMID 19574396 DOI: 10.1210/En.2009-0445  0.425
2009 Pamir N, McMillen TS, Kaiyala KJ, Schwartz MW, LeBoeuf RC. Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology. 150: 4124-34. PMID 19477937 DOI: 10.1210/En.2009-0137  0.43
2009 Schur EA, Kleinhans NM, Goldberg J, Buchwald D, Schwartz MW, Maravilla K. Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus. International Journal of Obesity (2005). 33: 653-61. PMID 19365394 DOI: 10.1038/Ijo.2009.56  0.399
2009 Sweet IR, Gilbert M, Maloney E, Hockenbery DM, Schwartz MW, Kim F. Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration. Diabetologia. 52: 921-31. PMID 19219423 DOI: 10.1007/S00125-009-1272-4  0.321
2009 Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, Niswender KD. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. American Journal of Physiology. Endocrinology and Metabolism. 296: E1003-12. PMID 19116375 DOI: 10.1152/Ajpendo.90377.2008  0.67
2009 Blevins JE, Morton GJ, Williams DL, Caldwell DW, Bastian LS, Wisse BE, Schwartz MW, Baskin DG. Forebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 296: R476-84. PMID 19109369 DOI: 10.1152/Ajpregu.90544.2008  0.733
2009 Williams DL, Baskin DG, Schwartz MW. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology. 150: 1680-7. PMID 19074583 DOI: 10.1210/En.2008-1045  0.68
2009 Sarruf DA, Yu F, Nguyen HT, Williams DL, Printz RL, Niswender KD, Schwartz MW. Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis. Endocrinology. 150: 707-12. PMID 18845632 DOI: 10.1210/En.2008-0899  0.598
2009 Baskin DG, White MF, Schwartz MW. P-2: Insulin and food intake increase neuronal phosphotyrosine levels in the arcuate nucleus of the rat hypothalamus Experimental and Clinical Endocrinology & Diabetes. 104: 66-67. DOI: 10.1055/S-0029-1211545  0.669
2009 Williams D, Schwartz M, Wisse B. The role of plasma leptin in the response to and recovery from a 24-h fast Appetite. 52: 865. DOI: 10.1016/J.Appet.2009.04.209  0.479
2009 Blevins J, Schwartz M, Russell B, Baskin D. Neurotoxic lesioning of oxytocin-sensing hindbrain neurons attenuates the satiety response to CCK-8 Appetite. 52: 820. DOI: 10.1016/J.Appet.2009.04.025  0.555
2008 Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1982-8. PMID 18772497 DOI: 10.1161/Atvbaha.108.169722  0.402
2008 Gelling RW, Yan W, Al-Noori S, Pardini A, Morton GJ, Ogimoto K, Schwartz MW, Dempsey PJ. Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology. 149: 6053-64. PMID 18687778 DOI: 10.1210/En.2008-0775  0.404
2008 Akesson L, Gelling RW, Jensen R, Ogimoto K, Fuller JM, Pefley R, Manavi S, Lernmark A, Schwartz MW. Increased lipid oxidation heralds diabetes onset in DR.lyp/lyp rats. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 116: 475-80. PMID 18465680 DOI: 10.1055/S-2008-1062713  0.322
2008 Williams DL, Schwartz MW, Bastian LS, Blevins JE, Baskin DG. Immunocytochemistry and laser capture microdissection for real-time quantitative PCR identify hindbrain neurons activated by interaction between leptin and cholecystokinin. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 56: 285-93. PMID 18040081 DOI: 10.1369/Jhc.7A7331.2007  0.697
2008 Blevins JE, Morton GJ, Williams DL, Schwartz MW. Histochemical approaches to understanding central regulation of food intake by melanocortin signaling The Faseb Journal. 22: 108-108. DOI: 10.1096/Fasebj.22.2_Supplement.108  0.552
2008 Sarruf D, Yu F, Nguyen H, Niswender K, Schwartz M, Niswender K, Schwartz M. PPARγ is expressed in hypothalamic neurons involved in food intake and energy homeostasis Appetite. 51: 397. DOI: 10.1016/J.Appet.2008.04.210  0.419
2007 Wisse BE, Kim F, Schwartz MW. Physiology. An integrative view of obesity. Science (New York, N.Y.). 318: 928-9. PMID 17991852 DOI: 10.1126/Science.1148032  0.317
2007 Wisse BE, Ogimoto K, Tang J, Harris MK, Raines EW, Schwartz MW. Evidence that lipopolysaccharide-induced anorexia depends upon central, rather than peripheral, inflammatory signals. Endocrinology. 148: 5230-7. PMID 17673516 DOI: 10.1210/En.2007-0394  0.339
2007 Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulation Research. 100: 1589-96. PMID 17478729 DOI: 10.1161/Circresaha.106.142851  0.44
2007 Wisse BE, Ogimoto K, Morton GJ, Williams DL, Schwartz MW. Central interleukin-1 (IL1) signaling is required for pharmacological, but not physiological, effects of leptin on energy balance. Brain Research. 1144: 101-6. PMID 17320056 DOI: 10.1016/J.Brainres.2007.01.073  0.553
2007 Williams D, Baskin D, Schwartz M. The role of intestinal glucagon-like peptide 1 in satiety. Appetite. 49: 340. DOI: 10.1016/J.Appet.2007.03.216  0.694
2006 Williams DL, Baskin DG, Schwartz MW. Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. Diabetes. 55: 3387-93. PMID 17130484 DOI: 10.2337/Db06-0558  0.74
2006 Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 443: 289-95. PMID 16988703 DOI: 10.1038/Nature05026  0.631
2006 Pardini AW, Nguyen HT, Figlewicz DP, Baskin DG, Williams DL, Kim F, Schwartz MW. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Research. 1112: 169-78. PMID 16925984 DOI: 10.1016/J.Brainres.2006.06.109  0.723
2006 Kaelin CB, Gong L, Xu AW, Yao F, Hockman K, Morton GJ, Schwartz MW, Barsh GS, MacKenzie RG. Signal transducer and activator of transcription (stat) binding sites but not stat3 are required for fasting-induced transcription of agouti-related protein messenger ribonucleic acid. Molecular Endocrinology (Baltimore, Md.). 20: 2591-602. PMID 16709597 DOI: 10.1210/Me.2006-0107  0.366
2006 Schwartz MW. Central nervous system regulation of food intake. Obesity (Silver Spring, Md.). 14: 1S-8S. PMID 16642956 DOI: 10.1038/Oby.2006.275  0.498
2006 Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers MG, Rhodes CJ, Schwartz MW. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metabolism. 3: 67-73. PMID 16399506 DOI: 10.1016/J.Cmet.2005.11.013  0.417
2006 Christianson MA, Schwartz MW, Suzuki N. Determinants of insulin availability in parenteral nutrition solutions. Jpen. Journal of Parenteral and Enteral Nutrition. 30: 6-9. PMID 16387892 DOI: 10.1177/014860710603000106  0.337
2006 Pardini AW, Williams DL, Baskin DG, Schwartz MW. 147 LOCALIZATION OF INSULIN RECEPTOR SUBSTRATE 2 IN BRAIN AREAS IMPORTANT FOR ENERGY HOMEOSTASIS. Journal of Investigative Medicine. 54: S105.3-S105. DOI: 10.2310/6650.2005.X0004.146  0.717
2006 Baskin DG, Williams DL, Schwartz MW. WITHDRAWN: Leptin enhances and fasting inhibits the anorexic response to Exendin-4 in the rat Appetite. DOI: 10.1016/J.Appet.2006.03.322  0.656
2005 Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW. Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metabolism. 2: 411-20. PMID 16330326 DOI: 10.1016/J.Cmet.2005.10.009  0.515
2005 Xu AW, Kaelin CB, Morton GJ, Ogimoto K, Stanhope K, Graham J, Baskin DG, Havel P, Schwartz MW, Barsh GS. Effects of hypothalamic neurodegeneration on energy balance. Plos Biology. 3: e415. PMID 16296893 DOI: 10.1371/Journal.Pbio.0030415  0.608
2005 Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Archives of Neurology. 62: 1539-44. PMID 16216936 DOI: 10.1001/Archneur.62.10.Noc50112  0.326
2005 Williams DL, Schwartz MW. Out of synch: Clock mutation causes obesity in mice. Cell Metabolism. 1: 355-6. PMID 16054082 DOI: 10.1016/J.Cmet.2005.05.007  0.513
2005 Morrison CD, Morton GJ, Niswender KD, Gelling RW, Schwartz MW. Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling. American Journal of Physiology. Endocrinology and Metabolism. 289: E1051-7. PMID 16046456 DOI: 10.1152/Ajpendo.00094.2005  0.472
2005 Kim F, Tysseling KA, Rice J, Gallis B, Haji L, Giachelli CM, Raines EW, Corson MA, Schwartz MW. Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells. Journal of Molecular and Cellular Cardiology. 39: 327-34. PMID 15978611 DOI: 10.1016/J.Yjmcc.2005.05.009  0.351
2005 Williams DL, Schwartz MW. The melanocortin system as a central integrator of direct and indirect controls of food intake. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 289: R2-3. PMID 15956761 DOI: 10.1152/Ajpregu.00226.2005  0.546
2005 Sindelar DK, Palmiter RD, Woods SC, Schwartz MW. Attenuated feeding responses to circadian and palatability cues in mice lacking neuropeptide Y. Peptides. 26: 2597-602. PMID 15923061 DOI: 10.1016/J.Peptides.2005.04.018  0.394
2005 Trevaskis J, Walder K, Foletta V, Kerr-Bayles L, McMillan J, Cooper A, Lee S, Bolton K, Prior M, Fahey R, Whitecross K, Morton GJ, Schwartz MW, Collier GR. Src homology 3-domain growth factor receptor-bound 2-like (endophilin) interacting protein 1, a novel neuronal protein that regulates energy balance. Endocrinology. 146: 3757-64. PMID 15919751 DOI: 10.1210/En.2005-0282  0.443
2005 Porte D, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes. 54: 1264-76. PMID 15855309 DOI: 10.2337/Diabetes.54.5.1264  0.65
2005 Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS. PI3K integrates the action of insulin and leptin on hypothalamic neurons. The Journal of Clinical Investigation. 115: 951-8. PMID 15761497 DOI: 10.1172/Jci24301  0.443
2005 Morton GJ, Blevins JE, Williams DL, Niswender KD, Gelling RW, Rhodes CJ, Baskin DG, Schwartz MW. Leptin action in the forebrain regulates the hindbrain response to satiety signals. The Journal of Clinical Investigation. 115: 703-10. PMID 15711637 DOI: 10.1172/Jci200522081  0.729
2005 Schwartz MW, Porte D. Diabetes, obesity, and the brain. Science (New York, N.Y.). 307: 375-9. PMID 15662002 DOI: 10.1126/Science.1104344  0.432
2004 Schwartz MW, Niswender KD. Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance? The Journal of Clinical Endocrinology and Metabolism. 89: 5889-97. PMID 15579732 DOI: 10.1210/Jc.2004-0906  0.37
2004 Niswender KD, Baskin DG, Schwartz MW. Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends in Endocrinology and Metabolism: Tem. 15: 362-9. PMID 15380807 DOI: 10.1016/J.Tem.2004.07.009  0.67
2004 Wisse BE, Ogimoto K, Morton GJ, Wilkinson CW, Frayo RS, Cummings DE, Schwartz MW. Physiological regulation of hypothalamic IL-1beta gene expression by leptin and glucocorticoids: implications for energy homeostasis. American Journal of Physiology. Endocrinology and Metabolism. 287: E1107-13. PMID 15304373 DOI: 10.1152/Ajpendo.00038.2004  0.331
2004 Gelling RW, Overduin J, Morrison CD, Morton GJ, Frayo RS, Cummings DE, Schwartz MW. Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology. 145: 4575-82. PMID 15256489 DOI: 10.1210/En.2004-0605  0.386
2004 Morton GJ, Mystkowski P, Matsumoto AM, Schwartz MW. Increased hypothalamic melanin concentrating hormone gene expression during energy restriction involves a melanocortin-independent, estrogen-sensitive mechanism. Peptides. 25: 667-74. PMID 15165723 DOI: 10.1016/J.Peptides.2004.02.007  0.433
2004 Sindelar DK, Ste Marie L, Miura GI, Palmiter RD, McMinn JE, Morton GJ, Schwartz MW. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology. 145: 3363-8. PMID 15064281 DOI: 10.1210/En.2003-1727  0.455
2004 Blevins JE, Schwartz MW, Baskin DG. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 287: R87-96. PMID 15044184 DOI: 10.1152/Ajpregu.00604.2003  0.648
2003 Blevins JE, Eakin TJ, Murphy JA, Schwartz MW, Baskin DG. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Research. 993: 30-41. PMID 14642828 DOI: 10.1016/J.Brainres.2003.08.036  0.64
2003 Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ. Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes. 52: 2928-34. PMID 14633853 DOI: 10.2337/Diabetes.52.12.2928  0.469
2003 Wisse BE, Schwartz MW, Cummings DE. Melanocortin signaling and anorexia in chronic disease states. Annals of the New York Academy of Sciences. 994: 275-81. PMID 12851326 DOI: 10.1111/J.1749-6632.2003.Tb03190.X  0.381
2003 Wisse BE, Schwartz MW. The skinny on neurotrophins. Nature Neuroscience. 6: 655-6. PMID 12830151 DOI: 10.1038/Nn0703-655  0.302
2003 Watson GS, Peskind ER, Asthana S, Purganan K, Wait C, Chapman D, Schwartz MW, Plymate S, Craft S. Insulin increases CSF Abeta42 levels in normal older adults. Neurology. 60: 1899-903. PMID 12821730 DOI: 10.1212/01.Wnl.0000065916.25128.25  0.358
2003 Morton GJ, Niswender KD, Rhodes CJ, Myers MG, Blevins JE, Baskin DG, Schwartz MW. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fa(k)/fa(k)) rats. Endocrinology. 144: 2016-24. PMID 12697710 DOI: 10.1210/En.2002-0115  0.617
2003 Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Current Pharmaceutical Design. 9: 795-800. PMID 12678878 DOI: 10.2174/1381612033455323  0.605
2003 Niswender KD, Schwartz MW. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Frontiers in Neuroendocrinology. 24: 1-10. PMID 12609497 DOI: 10.1016/S0091-3022(02)00105-X  0.471
2003 Bates SH, Stearns WH, Dundon TA, Schubert M, Tso AW, Wang Y, Banks AS, Lavery HJ, Haq AK, Maratos-Flier E, Neel BG, Schwartz MW, Myers MG. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature. 421: 856-9. PMID 12594516 DOI: 10.1038/Nature01388  0.386
2003 Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 51: 275-83. PMID 12588955 DOI: 10.1177/002215540305100302  0.609
2003 Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL. Is the energy homeostasis system inherently biased toward weight gain? Diabetes. 52: 232-8. PMID 12540591 DOI: 10.2337/Diabetes.52.2.232  0.668
2003 Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG, Seeley RJ, Schwartz MW. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes. 52: 227-31. PMID 12540590 DOI: 10.2337/Diabetes.52.2.227  0.642
2003 Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annual Review of Medicine. 54: 453-71. PMID 12414915 DOI: 10.1146/Annurev.Med.54.101601.152403  0.363
2002 Porte D, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutrition Reviews. 60: S20-9; discussion S6. PMID 12403080 DOI: 10.1301/002966402320634797  0.644
2002 Schwartz MW, Morton GJ. Obesity: keeping hunger at bay. Nature. 418: 595-7. PMID 12167841 DOI: 10.1038/418595A  0.354
2002 Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nature Reviews. Genetics. 3: 589-600. PMID 12154382 DOI: 10.1038/Nrg862  0.376
2002 Schwartz MW, Gelling RW. Rats lighten up with MCH antagonist. Nature Medicine. 8: 779-81. PMID 12152027 DOI: 10.1038/Nm0802-779  0.328
2002 Blevins JE, Schwartz MW, Baskin DG. Peptide signals regulating food intake and energy homeostasis. Canadian Journal of Physiology and Pharmacology. 80: 396-406. PMID 12056545 DOI: 10.1139/Y02-035  0.676
2002 Schwartz MW. Neuronal pathways regulating food intake and body adiposity. Annales D'Endocrinologie. 63: 117-20. PMID 11994673  0.324
2002 Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW. Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice. Diabetes. 51: 778-83. PMID 11872679 DOI: 10.2337/Diabetes.51.3.778  0.417
2002 Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 143: 239-46. PMID 11751615 DOI: 10.1210/Endo.143.1.8589  0.744
2001 Morton GJ, Schwartz MW. The NPY/AgRP neuron and energy homeostasis. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 25: S56-62. PMID 11840217 DOI: 10.1038/Sj.Ijo.0801915  0.53
2001 Baskin DG, Blevins JE, Schwartz MW. How the brain regulates food intake and body weight: the role of leptin. Journal of Pediatric Endocrinology & Metabolism : Jpem. 14: 1417-29. PMID 11837495  0.638
2001 Schwartz MW. Brain pathways controlling food intake and body weight. Experimental Biology and Medicine (Maywood, N.J.). 226: 978-81. PMID 11743132 DOI: 10.1177/153537020122601103  0.396
2001 Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG, Schwartz MW. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature. 413: 794-5. PMID 11677594 DOI: 10.1038/35101657  0.431
2001 Schwartz MW. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity. The Journal of Clinical Investigation. 108: 963-4. PMID 11581296 DOI: 10.1172/Jci14127  0.476
2001 Wisse BE, Schwartz MW. Role of melanocortins in control of obesity. Lancet. 358: 857-9. PMID 11567697 DOI: 10.1016/S0140-6736(01)06037-8  0.307
2001 Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology. 142: 3292-301. PMID 11459770 DOI: 10.1210/Endo.142.8.8324  0.392
2001 Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, Adan RA, Baskin DG, Schwartz MW, van Dijk G. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3639-45. PMID 11331393 DOI: 10.1523/Jneurosci.21-10-03639.2001  0.687
2000 McMinn JE, Baskin DG, Schwartz MW. Neuroendocrine mechanisms regulating food intake and body weight. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 1: 37-46. PMID 12119644 DOI: 10.1046/J.1467-789X.2000.00007.X  0.663
2000 McMinn JE, Sindelar DK, Havel PJ, Schwartz MW. Leptin deficiency induced by fasting impairs the satiety response to cholecystokinin. Endocrinology. 141: 4442-8. PMID 11108253 DOI: 10.1210/Endo.141.12.7815  0.449
2000 Mystkowski P, Seeley RJ, Hahn TM, Baskin DG, Havel PJ, Matsumoto AM, Wilkinson CW, Peacock-Kinzig K, Blake KA, Schwartz MW. Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8637-42. PMID 11069973 DOI: 10.1523/Jneurosci.20-22-08637.2000  0.622
2000 Mystkowski P, Schwartz MW. Gonadal steroids and energy homeostasis in the leptin era. Nutrition (Burbank, Los Angeles County, Calif.). 16: 937-46. PMID 11054599 DOI: 10.1016/S0899-9007(00)00458-5  0.434
2000 Schwartz MW. Biomedicine. Staying slim with insulin in mind. Science (New York, N.Y.). 289: 2066-7. PMID 11032558 DOI: 10.1126/Science.289.5487.2066  0.453
2000 Baskin DG, Breininger JF, Schwartz MW. SOCS-3 expression in leptin-sensitive neurons of the hypothalamus of fed and fasted rats. Regulatory Peptides. 92: 9-15. PMID 11024559 DOI: 10.1016/S0167-0115(00)00143-9  0.643
2000 Cummings DE, Schwartz MW. Melanocortins and body weight: a tale of two receptors. Nature Genetics. 26: 8-9. PMID 10973234 DOI: 10.1038/79223  0.415
2000 Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes. 49: 1525-33. PMID 10969837 DOI: 10.2337/Diabetes.49.9.1525  0.447
2000 McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 279: R695-703. PMID 10938261 DOI: 10.1152/Ajpregu.2000.279.2.R695  0.41
2000 Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC, Seeley RJ. Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 279: R47-52. PMID 10896863 DOI: 10.1152/Ajpregu.2000.279.1.R47  0.413
2000 Havel PJ, Hahn TM, Sindelar DK, Baskin DG, Dallman MF, Weigle DS, Schwartz MW. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes. 49: 244-52. PMID 10868941 DOI: 10.2337/Diabetes.49.2.244  0.64
2000 Benoit S, Schwartz M, Baskin D, Woods SC, Seeley RJ. CNS melanocortin system involvement in the regulation of food intake. Hormones and Behavior. 37: 299-305. PMID 10860674 DOI: 10.1006/Hbeh.2000.1588  0.646
2000 Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, Seeley RJ. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 3442-8. PMID 10777807 DOI: 10.1523/Jneurosci.20-09-03442.2000  0.433
2000 Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 404: 661-71. PMID 10766253 DOI: 10.1038/35007534  0.647
2000 Woods SC, Schwartz MW, Baskin DG, Seeley RJ. Food intake and the regulation of body weight. Annual Review of Psychology. 51: 255-77. PMID 10751972 DOI: 10.1146/Annurev.Psych.51.1.255  0.655
2000 Porte D, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Comments on the relation among GAD-65, IA-2 antibodies and body adiposity. Diabetologia. 43: 134. PMID 10672457  0.478
2000 Craft S, Peskind E, Asthana S, Stennis Watson G, Baker LD, Cook DD, Schwartz MW. Effects of insulin on cerebrospinal fluid levels of Aβ42 Neurobiology of Aging. 21: 272. DOI: 10.1016/S0197-4580(00)83176-0  0.334
1999 van Dijk G, Seeley RJ, Thiele TE, Friedman MI, Ji H, Wilkinson CW, Burn P, Campfield LA, Tenenbaum R, Baskin DG, Woods SC, Schwartz MW. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 276: R1425-R1433. PMID 29592687 DOI: 10.1152/ajpregu.1999.276.5.R1425  0.625
1999 Schwartz MW, Kahn SE. Insulin resistance and obesity. Nature. 402: 860-1. PMID 10622250 DOI: 10.1038/47209  0.382
1999 Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D, Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Research. 848: 114-23. PMID 10612703 DOI: 10.1016/S0006-8993(99)01974-5  0.701
1999 Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Research. 848: 66-77. PMID 10612698 DOI: 10.1016/S0006-8993(99)01962-9  0.429
1999 Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D, Schwartz MW. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. The American Journal of Physiology. 277: E659-67. PMID 10516125 DOI: 10.1152/Ajpendo.1999.277.4.E659  0.401
1999 Baskin DG, Hahn TM, Schwartz MW. Leptin sensitive neurons in the hypothalamus. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Mã©Tabolisme. 31: 345-50. PMID 10422733 DOI: 10.1055/S-2007-978751  0.686
1999 Sindelar DK, Havel PJ, Seeley RJ, Wilkinson CW, Woods SC, Schwartz MW. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes. 48: 1275-80. PMID 10342816 DOI: 10.2337/Diabetes.48.6.1275  0.374
1999 van Dijk G, Seeley RJ, Thiele TE, Friedman MI, Ji H, Wilkinson CW, Burn P, Campfield LA, Tenenbaum R, Baskin DG, Woods SC, Schwartz MW. Metabolic, gastrointestinal, and CNS neuropeptide effects of brain leptin administration in the rat. The American Journal of Physiology. 276: R1425-33. PMID 10233036 DOI: 10.1152/Ajpregu.1999.276.5.R1425  0.662
1999 Schwartz MW, Baskin DG, Kaiyala KJ, Woods SC. Model for the regulation of energy balance and adiposity by the central nervous system. The American Journal of Clinical Nutrition. 69: 584-96. PMID 10197558  0.579
1999 Baskin DG, Breininger JF, Schwartz MW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 48: 828-33. PMID 10102700 DOI: 10.2337/Diabetes.48.4.828  0.638
1999 Seeley RJ, Schwartz MW. Neuroendocrine regulation of food intake. Acta Paediatrica (Oslo, Norway : 1992). Supplement. 88: 58-61. PMID 10102053 DOI: 10.1111/J.1651-2227.1999.Tb14352.X  0.416
1999 Hagan MM, Rushing PA, Schwartz MW, Yagaloff KA, Burn P, Woods SC, Seeley RJ. Role of the CNS melanocortin system in the response to overfeeding. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2362-7. PMID 10066286 DOI: 10.1523/Jneurosci.19-06-02362.1999  0.433
1999 Baskin DG, Schwartz MW, Seeley RJ, Woods SC, Porte D, Breininger JF, Jonak Z, Schaefer J, Krouse M, Burghardt C, Campfield LA, Burn P, Kochan JP. Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 353-62. PMID 10026237 DOI: 10.1177/002215549904700309  0.623
1998 Thiele TE, Van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 274: R248-R254. PMID 29592157 DOI: 10.1152/ajpregu.1998.274.1.R248  0.33
1998 Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience. 1: 271-2. PMID 10195157 DOI: 10.1038/1082  0.65
1998 McMinn JE, Seeley RJ, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW. NPY-induced overfeeding suppresses hypothalamic NPY mRNA expression: potential roles of plasma insulin and leptin. Regulatory Peptides. 75: 425-31. PMID 9802439 DOI: 10.1016/S0167-0115(98)00098-6  0.479
1998 Porte D, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia. 41: 863-81. PMID 9726588 DOI: 10.1007/S001250051002  0.569
1998 Chavez M, Seeley RJ, Havel PJ, Friedman MI, Matson CA, Woods SC, Schwartz MW. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. The Journal of Clinical Investigation. 102: 340-6. PMID 9664075 DOI: 10.1172/Jci603  0.404
1998 Woods SC, Seeley RJ, Porte D, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science (New York, N.Y.). 280: 1378-83. PMID 9603721 DOI: 10.1126/Science.280.5368.1378  0.383
1998 Baskin DG, Seeley RJ, Kuijper JL, Lok S, Weigle DS, Erickson JC, Palmiter RD, Schwartz MW. Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes. 47: 538-43. PMID 9568684 DOI: 10.2337/Diabetes.47.4.538  0.64
1998 Schwartz MW, Erickson JC, Baskin DG, Palmiter RD. Effect of fasting and leptin deficiency on hypothalamic neuropeptide Y gene transcription in vivo revealed by expression of a lacZ reporter gene. Endocrinology. 139: 2629-35. PMID 9564880 DOI: 10.1210/Endo.139.5.6000  0.612
1998 Schwartz MW. Orexins and appetite: the big picture of energy homeostasis gets a little bigger. Nature Medicine. 4: 385-6. PMID 9546775 DOI: 10.1038/Nm0498-385  0.422
1998 Weigle DS, Selfridge LE, Schwartz MW, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL, BeltrandelRio H. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes. 47: 298-302. PMID 9519732 DOI: 10.2337/Diab.47.2.298  0.327
1998 Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. The American Journal of Physiology. 274: R248-54. PMID 9458925 DOI: 10.1152/Ajpregu.1998.274.1.R248  0.44
1998 Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 50: 164-8. PMID 9443474 DOI: 10.1212/Wnl.50.1.164  0.338
1997 Schwartz MW, Strack AM, Dallman MF. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Regulatory Peptides. 72: 105-12. PMID 9652969 DOI: 10.1016/S0167-0115(97)01043-4  0.338
1997 Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes. 46: 2119-23. PMID 9392508 DOI: 10.2337/Diab.46.12.2119  0.643
1997 Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW. Melanocortin receptors in leptin effects. Nature. 390: 349. PMID 9389472 DOI: 10.1038/37016  0.639
1997 Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ, Porte D. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care. 20: 1476-81. PMID 9283801 DOI: 10.2337/Diacare.20.9.1476  0.407
1997 Chavez M, Seeley RJ, Green PK, Wilkinson CW, Schwartz MW, Woods SC. Adrenalectomy increases sensitivity to central insulin. Physiology & Behavior. 62: 631-4. PMID 9272675 DOI: 10.1016/S0031-9384(97)00188-1  0.483
1997 Schwartz MW. Regulation of appetite and body weight. Hospital Practice (1995). 32: 109-12, 117-9. PMID 9227661 DOI: 10.1080/21548331.1997.11443528  0.414
1997 Schwartz MW, Seeley RJ. Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. The New England Journal of Medicine. 336: 1802-11. PMID 9187072 DOI: 10.1056/Nejm199706193362507  0.322
1997 Schwartz MW, Brunzell JD. Regulation of body adiposity and the problem of obesity. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 233-8. PMID 9081675 DOI: 10.1161/01.Atv.17.2.233  0.358
1997 Schwartz MW, Seeley RJ. The new biology of body weight regulation. Journal of the American Dietetic Association. 97: 54-8; quiz 59-60. PMID 8990418 DOI: 10.1016/S0002-8223(97)00018-7  0.458
1996 Seeley RJ, van Dijk G, Campfield LA, Smith FJ, Burn P, Nelligan JA, Bell SM, Baskin DG, Woods SC, Schwartz MW. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 28: 664-8. PMID 9013738 DOI: 10.1055/S-2007-979874  0.666
1996 Seeley RJ, Matson CA, Chavez M, Woods SC, Dallman MF, Schwartz MW. Behavioral, endocrine, and hypothalamic responses to involuntary overfeeding. The American Journal of Physiology. 271: R819-23. PMID 8853408 DOI: 10.1152/Ajpregu.1996.271.3.R819  0.495
1996 Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. The Journal of Clinical Investigation. 98: 1101-6. PMID 8787671 DOI: 10.1172/Jci118891  0.689
1996 Figlewicz DP, Schwartz MW, Seeley RJ, Chavez M, Baskin DG, Woods SC, Porte D. Endocrine regulation of food intake and body weight. The Journal of Laboratory and Clinical Medicine. 127: 328-32. PMID 8656034 DOI: 10.1016/S0022-2143(96)90179-1  0.63
1996 Woods SC, Chavez M, Park CR, Riedy C, Kaiyala K, Richardson RD, Figlewicz DP, Schwartz MW, Porte D, Seeley RJ. The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neuroscience and Biobehavioral Reviews. 20: 139-44. PMID 8622820 DOI: 10.1016/0149-7634(95)00044-F  0.493
1996 Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Medicine. 2: 589-93. PMID 8616722 DOI: 10.1038/Nm0596-589  0.38
1996 Porte D, Schwartz MW. Diabetes complications: why is glucose potentially toxic? Science (New York, N.Y.). 272: 699-700. PMID 8614830 DOI: 10.1126/Science.272.5262.699  0.311
1996 Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45: 531-5. PMID 8603777 DOI: 10.2337/Diab.45.4.531  0.667
1996 Baura GD, Foster DM, Kaiyala K, Porte D, Kahn SE, Schwartz MW. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes. 45: 86-90. PMID 8522065 DOI: 10.2337/Diab.45.1.86  0.413
1995 Sipols AJ, Baskin DG, Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes. 44: 147-51. PMID 7859932 DOI: 10.2337/Diab.44.2.147  0.646
1995 Strack AM, Sebastian RJ, Schwartz MW, Dallman MF. Glucocorticoids and insulin: reciprocal signals for energy balance. The American Journal of Physiology. 268: R142-9. PMID 7840315 DOI: 10.1152/Ajpregu.1995.268.1.R142  0.498
1995 Antonelli MC, Costa Lieste M, Baskin DG, Stahl WL, Schwartz MW. Localization of Na, K-ATPase isoforms in the hypothalamus of the rat. Cellular and Molecular Biology (Noisy-Le-Grand, France). 41: 79-85. PMID 7773139  0.483
1995 Schwartz MW, Boyko EJ, Kahn SE, Ravussin E, Bogardus C. Reduced insulin secretion: an independent predictor of body weight gain. The Journal of Clinical Endocrinology and Metabolism. 80: 1571-6. PMID 7745002 DOI: 10.1210/Jcem.80.5.7745002  0.434
1995 Chavez M, Kaiyala K, Madden LJ, Schwartz MW, Woods SC. Intraventricular insulin and the level of maintained body weight in rats. Behavioral Neuroscience. 109: 528-31. PMID 7662162 DOI: 10.1037//0735-7044.109.3.528  0.354
1995 Baskin DG, Norwood BJ, Schwartz MW, Koerker DJ. Estradiol inhibits the increase of hypothalamic neuropeptide Y messenger ribonucleic acid expression induced by weight loss in ovariectomized rats. Endocrinology. 136: 5547-54. PMID 7588307 DOI: 10.1210/Endo.136.12.7588307  0.607
1995 Schwartz MW, Dallman MF, Woods SC. Hypothalamic response to starvation: implications for the study of wasting disorders. The American Journal of Physiology. 269: R949-57. PMID 7503322 DOI: 10.1152/Ajpregu.1995.269.5.R949  0.377
1995 Kaiyala KJ, Woods SC, Schwartz MW. New model for the regulation of energy balance and adiposity by the central nervous system. The American Journal of Clinical Nutrition. 62: 1123S-1134S. PMID 7484931 DOI: 10.1093/Ajcn/62.5.1123S  0.418
1994 Verchere CB, Kowalyk S, Shen GH, Brown MR, Schwartz MW, Baskin DG, Taborsky GJ. Major species variation in the expression of galanin messenger ribonucleic acid in mammalian celiac ganglion. Endocrinology. 135: 1052-9. PMID 7520862 DOI: 10.1210/Endo.135.3.7520862  0.58
1994 Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology. 134: 1952-5. PMID 7511094 DOI: 10.1210/Endo.134.4.7511094  0.638
1993 Baskin DG, Gierke EP, Wilcox BJ, Matsumoto AM, Schwartz MW. Food intake and estradiol effects on insulin binding in brain and liver. Physiology & Behavior. 53: 757-62. PMID 8511182 DOI: 10.1016/0031-9384(93)90185-I  0.653
1993 Israel PA, Park CR, Schwartz MW, Green PK, Sipols AJ, Woods SC, Porte D, Figlewicz DP. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain Research Bulletin. 30: 571-5. PMID 8457906 DOI: 10.1016/0361-9230(93)90084-O  0.428
1993 Baura GD, Foster DM, Porte D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. The Journal of Clinical Investigation. 92: 1824-30. PMID 8408635 DOI: 10.1172/Jci116773  0.389
1993 Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42: 1663-72. PMID 8405710 DOI: 10.2337/Diab.42.11.1663  0.35
1993 Schwartz MW, Figlewicz DP, Woods SC, Porte D, Baskin DG. Insulin, neuropeptide Y, and food intake. Annals of the New York Academy of Sciences. 692: 60-71. PMID 8215045 DOI: 10.1111/J.1749-6632.1993.Tb26206.X  0.64
1993 Boswell T, Richardson RD, Schwartz MW, D'Alessio DA, Woods SC, Sipols AJ, Baskin DG, Kenagy GJ. NPY and galanin in a hibernator: hypothalamic gene expression and effects on feeding. Brain Research Bulletin. 32: 379-84. PMID 7693306 DOI: 10.1016/0361-9230(93)90203-N  0.638
1993 Schwartz MW, Sipols AJ, Grubin CE, Baskin DG. Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Research Bulletin. 31: 361-7. PMID 7683962 DOI: 10.1016/0361-9230(93)90228-4  0.621
1993 Baskin DG, Sipols AJ, Schwartz MW, White MF. Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine. Regulatory Peptides. 48: 257-66. PMID 7505468 DOI: 10.1016/0167-0115(93)90355-C  0.637
1992 Marks JL, Li M, Schwartz M, Porte D, Baskin DG. Effect of fasting on regional levels of neuropeptide Y mRNA and insulin receptors in the rat hypothalamus: An autoradiographic study. Molecular and Cellular Neurosciences. 3: 199-205. PMID 19912861 DOI: 10.1016/1044-7431(92)90039-5  0.632
1992 Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte D. Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism. 74: 192-7. PMID 1727820 DOI: 10.1210/Jcem.74.1.1727820  0.375
1992 Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130: 3608-16. PMID 1597158 DOI: 10.1210/Endo.130.6.1597158  0.658
1992 Kahn SE, Bergman RN, Schwartz MW, Taborsky GJ, Porte D. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. The American Journal of Physiology. 262: E518-23. PMID 1566838 DOI: 10.1152/Ajpendo.1992.262.4.E518  0.374
1992 Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. Insulin in the brain: a hormonal regulator of energy balance. Endocrine Reviews. 13: 387-414. PMID 1425482 DOI: 10.1210/Edrv-13-3-387  0.622
1991 Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Porte D. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 128: 2645-7. PMID 2019270 DOI: 10.1210/Endo-128-5-2645  0.673
1991 Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ, Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. The Journal of Clinical Investigation. 88: 1272-81. PMID 1918377 DOI: 10.1172/Jci115431  0.348
1991 McCulloch DK, Kahn SE, Schwartz MW, Koerker DJ, Palmer JP. Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons. The Journal of Clinical Investigation. 87: 1395-401. PMID 1826300 DOI: 10.1172/Jci115145  0.381
1990 Kahn SE, Klaff LJ, Schwartz MW, Beard JC, Bergman RN, Taborsky GJ, Porte D. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. The Journal of Clinical Endocrinology and Metabolism. 71: 994-1002. PMID 2205630 DOI: 10.1210/Jcem-71-4-994  0.329
1990 Schwartz MW, Sipols A, Kahn SE, Lattemann DF, Taborsky GJ, Bergman RN, Woods SC, Porte D. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. The American Journal of Physiology. 259: E378-83. PMID 2205107 DOI: 10.1152/Ajpendo.1990.259.3.E378  0.376
1990 Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, Porte D. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides. 11: 467-72. PMID 2199946 DOI: 10.1016/0196-9781(90)90044-6  0.635
1990 Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism. 70: 1247-53. PMID 2186054 DOI: 10.1210/Jcem-70-5-1247  0.358
1990 Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 39: 634-8. PMID 2185112 DOI: 10.2337/Diab.39.5.634  0.336
1990 Woods SC, Figlewicz Lattemann DP, Schwartz MW, Porte D. A re-assessment of the regulation of adiposity and appetite by the brain insulin system. International Journal of Obesity. 14: 69-73; discussion 74. PMID 2086517  0.34
1989 Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ, Porte D. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 38: 562-8. PMID 2653928 DOI: 10.2337/Diab.38.5.562  0.367
Show low-probability matches.